Copart (CPRT) Could Be 40% Below Fair Value On Strong Q3 Results

Copart (CPRT) reported Q3 2026 results that came in ahead of expectations, yet the stock remains under pressure as investors focus on softer insurance auction volumes and the mixed signals this sends about future demand.

See our latest analysis for Copart.

At a latest share price of US$29.40, Copart’s stock has been under pressure, with the share price return down 22.16% year to date and the 1 year total shareholder return declining 36.84%. This suggests momentum has been fading despite the stronger Q3 report.

If Copart’s recent moves have you reassessing opportunities in the market, it could be a good moment to broaden your search and check out 19 top founder-led companies

Bulls see Copart’s recent share price weakness against solid Q3 numbers as an opening. Bears point to softer insurance auction volumes. The valuation section next weighs which side today’s evidence leans toward.

Most Popular Copart Narrative: 40% Undervalued

According to the most widely followed narrative on Copart, the fair value sits at $49.00 compared with the latest close at $29.40, which implies a sizable valuation gap that investors are actively debating.

The market is treating Copart like a broken growth stock. I think it may be pricing a temporary slowdown as permanent decline.

Copart is no longer growing like the premium compounder investors once celebrated.

Read the complete narrative.

This narrative leans on Copart’s long record of profit growth, its high margins and a relatively low discount rate to justify a higher fair value. It also builds in expectations that the international segment continues to scale while the core US business supports strong cash generation. The result is a valuation that treats today’s slowdown as a temporary phase rather than a structural ceiling.

Result: Fair Value of $49 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Copart’s story can still break if US insurance auction volumes weaken further or if international expansion fails to reach the scale that current narratives assume.

Find out about the key risks to this Copart narrative.

Next Steps

If the mixed sentiment around Copart has you on the fence, this is a good time to look through the data yourself and stress test the assumptions behind each narrative. To understand what investors currently see as the main positives, take a closer look at the 4 key rewards.

Looking for more investment ideas beyond Copart?

If Copart has you thinking more carefully about where to put fresh capital, do not stop here. The screener can surface other opportunities that fit your style.

• Target resilient returns by focusing on companies with sturdy finances using the solid balance sheet and fundamentals stocks screener (49 results).
• Hunt for potential value opportunities that the market may be overlooking through the 52 high quality undervalued stocks.
• Prioritise stability and peace of mind by concentrating on 82 resilient stocks with low risk scores before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com